Exhibit 10.3
JOINDER AGREEMENT AND AMENDMENT
(New Term Loans)
JOINDER AGREEMENT AND AMENDMENT (this “Agreement”), dated as of July 1, 2018, by and among each of the New Term Loan Lenders set forth on the signature pages hereto (each, a “New Term Loan Lender”), Aveanna Healthcare LLC, a Delaware limited liability company (the “Borrower”), the other Credit Parties, Barclays Bank PLC, as the Administrative Agent (the “Administrative Agent”) and the Revolving Credit Lenders party hereto (constituting Required Revolving Credit Lenders).
RECITALS:
WHEREAS, reference is hereby made to the First Lien Credit Agreement, dated as of March 16, 2017 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), among Aveanna Healthcare Intermediate Holdings LLC (f/k/a BCPE Eagle Intermediate Holdings LLC), a Delaware limited liability company, the Borrower (f/k/a BCPE Eagle Buyer LLC), the lending institutions from time to time party thereto, and Barclays Bank PLC, as the Administrative Agent, the Collateral Agent, a Letter of Credit Issuer, and a Lender (capitalized terms used but not defined herein having the meaning provided in the Credit Agreement);
WHEREAS, subject to the terms and conditions of the Credit Agreement, the Borrower may establish New Term Loan Commitments by, among other things, entering into one or more Joinder Agreements with New Term Loan Lenders, as applicable;
WHEREAS, the Administrative Agent and the Borrower may amend the Credit Agreement and the other Credit Documents without the consent of any other party as may be necessary or appropriate, in the reasonable opinion of the Administrative Agent and the Borrower, to effect the terms of any incremental facility in accordance with Section 2.14 of the Credit Agreement;
WHEREAS, the Borrower has requested that (i) the New Term Loan Lenders having Initial New Term Loan Commitments (as defined below) as set forth on Schedule 1 hereto provide $171,000,000 of New Term Loans to be drawn on the New Term Loan Closing Date (as defined below) (the “Initial New Term Loans”) and (ii) the New Term Loan Lenders having Delayed Draw New Term Loan Commitments (as defined below) as set forth on Schedule 1 hereto provide up to $50,000,000 of New Term Loans in the form of delayed draw advances (the “Delayed Draw New Term Loans” and together with the Initial New Term Loans, the “New Term Loans”);
WHEREAS, the Borrower intends to use the proceeds of the Initial New Term Loans, together with proceeds of any equity contribution or issuance, certain proceeds of Revolving Credit Loans, if any, and cash on hand to (i) fund the acquisition by the Borrower (the “Premier Acquisition”), directly or indirectly, of all of the outstanding equity interests of Premier Healthcare Services, LLC (“Premier”) pursuant to that certain Interest Purchase Agreement, dated as of May 1, 2018, by and among the Borrower, Premier and each of the sellers party thereto (together with the schedules and exhibits thereto, the “Premier Acquisition Agreement”) (ii) repay in full (or to terminate, discharge or defease (or make other arrangements reasonably satisfactory to the New Term Loan Lead Arrangers for the termination, discharge or defeasance)) of all outstanding indebtedness and guarantees and security in respect thereof (the “Premier Refinancing” and, together with the Premier Acquisition, the borrowing of the New Term Loans and the consummation of any other transaction contemplated herein or in connection with the foregoing, the “New Term Loan Transactions”) under (x) that certain Loan